SEC Form 4 · accession 0001189724-17-000003

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Steven Riggs

Officer — VP Operations

Period of report

Feb 24, 2017

Accepted (ET)

Feb 27, 2017 · 2:12 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 24, 2017	X	16,250	$58.79	A	17,576	D
Common Stock^F2	Feb 24, 2017	S	4,500	$151.3881	D	13,076	D
Common Stock^F3	Feb 24, 2017	S	11,750	$152.2282	D	1,326	D
Common Stock	Feb 24, 2017	X	15,000	$58.79	A	16,326	D
Common Stock^F4	Feb 24, 2017	S	4,796	$151.4907	D	11,530	D
Common Stock^F5	Feb 24, 2017	S	10,204	$152.2044	D	1,326	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F7,F6	$58.79	Feb 24, 2017	X	16,250	D	—	Feb 24, 2024	Common Stock	16,250	46,250	D
Non-Qualified Stock Option (right to buy)^F7,F6	$58.79	Feb 24, 2017	X	15,000	D	—	Feb 24, 2024	Common Stock	15,000	31,250	D

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
F7Transaction is the exercise of a derivative security; see Column 2.